What insulin is covered by Medicare Part D 2026?

📌 Medicare Part D Insulin Coverage in 2026

Medicare Part D covers almost all commercially available, self-administered injectable and inhaled insulins, provided they are on your specific plan's formulary (drug list).

💡 Covered Insulin Categories & Brand Examples

• Long-Acting: Lantus, Levemir, Tresiba, Toujeo, Basaglar
• Rapid-Acting / Short-Acting: Novolog, Fiasp, Humalog, Admelog, Afrezza (inhaled)
• Intermediate & Premixed: Novolin 70/30, Novolog Mix 70/30
• Combination / Concentrated: Soliqua, Xultophy
• Biosimilars: Semglee, Rezvoglar

📊 2026 Cost Rules & Protections

• Monthly Cost Cap: You pay a maximum of $35 for a one-month (30-day) supply of each covered insulin product.
• Deductible Waived: The $35 cap applies immediately; you do not have to meet your Part D deductible first.
• Supplies Included: Part D also covers necessary injection supplies like syringes, needles, alcohol swabs, and gauze.
• Note: Specific brand availability depends on your individual private plan’s formulary tier, though nationally negotiated insulins like Novolog and Fiasp are widely integrated.

Yes, Medicare Part D covers insulin pens as long as the specific brand is on your plan's approved list, known as a formulary.

Coverage Details

• Insulin Cost: You pay a maximum of $35 for a one-month supply of each covered insulin product.
• Deductible: Your yearly Part D deductible does not apply to covered insulin.
• Supplies: Part D also helps cover related injection supplies, such as needles and syringes used with pens.

What to Check

• Plan Formularies: Not every plan covers every brand of insulin pen. Check your specific plan details.
• Medicare Advantage: If you have a Medicare Advantage plan with drug coverage (MAPD), it follows these same rules.

Under Medicare Part D, your out-of-pocket cost for a one-month (30-day) supply of each covered insulin product is capped at a maximum of $35. Thanks to the Inflation Reduction Act, you also do not have to pay a deductible for your insulin; the $35 price ceiling applies starting with your very first prescription fill of the calendar year.

Important Details About the Insulin Cap

• Per-Product Limit: The $35 cap applies to each covered insulin product individually. If you take two different types of covered insulin (e.g., a fast-acting and a long-acting insulin), you will pay up to $35 for each, totaling $70 a month.
• Potential for Lower Costs: Your copay could be even less than $35. Your actual payment will be the lowest option among $35, 25% of the plan's regular negotiated price, or 25% of the Medicare-negotiated Maximum Fair Price.
• 90-Day Supplies: If you get a three-month supply all at once, your cost is capped at $35 per month, meaning you will pay no more than $105 for the full 90 days.
• Formulary Requirement: The insulin must be on your specific Medicare Part D plan's list of covered drugs (formulary) for the cap to apply automatically.

What Else Is Covered?

• Injected & Inhaled Insulin: Part D covers injectable insulins (via pens or vials) and inhaled insulins.
• Supplies: Medical supplies needed to administer insulin—such as syringes, needles, gauze, and alcohol swabs—are generally covered under Part D, though standard plan cost-sharing or deductibles may apply to these items.

(Note: If you use a traditional, durable medical equipment insulin pump, your insulin is instead covered under Medicare Part B, but it features the exact same $35 monthly cap and deductible waiver).

To verify if your specific brand of insulin is covered under your plan, you can use the official Medicare Plan Finder Tool.

Yes, insulin is still capped at no more than $35 per month for a one-month supply of each covered insulin product for Medicare patients.

Key Details on the $35 Insulin Cap

• Medicare Part D: Covers retail injectable and inhaled insulin, capping costs at $35 per month per product with no deductible.
• Medicare Part B: Covers insulin used through a traditional traditional durable medical equipment (DME) infusion pump, also capped at $35 per month with no deductible.
• No Deductibles: You do not have to pay a yearly deductible before the $35 cap kicks in for covered insulin.
• Multiple Months: If you order a three-month supply, you will pay no more than $105 total per covered product ($35 per month).
• Official Information: You can review official updates and covered products directly on the Medicare Insulin Coverage Page.

There is no single "best" Medicare Part D plan for diabetics because coverage, formularies (drug lists), and costs vary by your specific location and the exact medications you take.

However, top-rated national providers like Wellcare and Humana offer strong overall Part D options, and federal rules ensure consistent baseline savings for diabetes care.

Key Protections for Diabetics on Medicare Part D

• Capped Insulin Costs: Under Medicare rules, all Part D plans must cap covered insulin costs at a maximum of $35 per month with no deductible for that insulin.
• Covered Medications: Part D typically covers anti-diabetic oral medications (like metformin), non-pump insulins, and injectable GLP-1 receptor agonists (like Trulicity), though specific tier placements vary.
• Supplies: Part D covers certain diabetic supplies not paid for by Part B, such as syringes, needles, and gauze.

Top-Rated Part D Providers

• Wellcare: Frequently recognized for low monthly premiums and $0 copays on select generic drugs.
• Humana: Noted for low out-of-pocket costs and strong customer support features.
• UnitedHealthcare (AARP): Offers broad pharmacy networks and plans tailored for different budget and coverage levels.

How to Find the Best Plan for You

1. Make a complete list of your current diabetic medications, testing supplies, and dosages.
2. Use the official Medicare Plan Finder tool and enter your ZIP code and medications.
3. Compare the total estimated annual cost (monthly premium plus copays/deductibles) rather than just looking at the lowest premium.
4. Check if your preferred local pharmacy is in the plan’s preferred network.